Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 15 studies | 25% ± 5% | |
adipocyte | 7 studies | 38% ± 14% | |
smooth muscle cell | 6 studies | 19% ± 4% | |
pericyte | 6 studies | 19% ± 4% | |
astrocyte | 3 studies | 21% ± 3% |
Insufficient scRNA-seq data for expression of ECM2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 99% | 4009.97 | 454 / 459 | 92% | 17.29 | 1029 / 1118 |
liver | 85% | 1342.89 | 193 / 226 | 85% | 13.32 | 347 / 406 |
lung | 90% | 1820.18 | 518 / 578 | 75% | 6.81 | 866 / 1155 |
thymus | 94% | 1776.42 | 611 / 653 | 69% | 5.32 | 418 / 605 |
prostate | 78% | 1174.98 | 190 / 245 | 85% | 7.81 | 427 / 502 |
ovary | 100% | 5766.65 | 180 / 180 | 46% | 3.38 | 196 / 430 |
uterus | 99% | 2669.07 | 168 / 170 | 33% | 2.92 | 151 / 459 |
kidney | 53% | 614.91 | 47 / 89 | 74% | 11.59 | 669 / 901 |
esophagus | 53% | 763.72 | 761 / 1445 | 69% | 5.09 | 126 / 183 |
adrenal gland | 41% | 409.27 | 105 / 258 | 67% | 7.30 | 155 / 230 |
adipose | 100% | 5296.89 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7922.42 | 1335 / 1335 | 0% | 0 | 0 / 0 |
brain | 12% | 148.80 | 322 / 2642 | 87% | 18.61 | 615 / 705 |
skin | 64% | 1071.03 | 1164 / 1809 | 28% | 2.31 | 130 / 472 |
pancreas | 2% | 20.64 | 8 / 328 | 88% | 11.07 | 156 / 178 |
intestine | 48% | 631.00 | 465 / 966 | 34% | 3.07 | 179 / 527 |
bladder | 43% | 514.10 | 9 / 21 | 36% | 2.67 | 182 / 504 |
stomach | 22% | 287.65 | 80 / 359 | 56% | 5.32 | 160 / 286 |
heart | 73% | 1382.13 | 632 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 47% | 3.07 | 21 / 45 |
muscle | 19% | 198.68 | 156 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.26 | 2 / 29 |
eye | 0% | 0 | 0 / 0 | 4% | 0.19 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0010811 | Biological process | positive regulation of cell-substrate adhesion |
GO_0007160 | Biological process | cell-matrix adhesion |
GO_0005614 | Cellular component | interstitial matrix |
GO_0005576 | Cellular component | extracellular region |
GO_0031012 | Cellular component | extracellular matrix |
GO_0070052 | Molecular function | collagen V binding |
GO_0008201 | Molecular function | heparin binding |
GO_0005178 | Molecular function | integrin binding |
Gene name | ECM2 |
Protein name | Extracellular matrix protein 2 ECM2 protein Extracellular matrix protein 2 (Matrix glycoprotein SC1/ECM2) |
Synonyms | |
Description | FUNCTION: Promotes matrix assembly and cell adhesiveness. . |
Accessions | ENST00000444490.6 [O94769-2] Q6PID0 ENST00000395534.2 ENST00000707290.1 [O94769-2] Q5T9F4 ENST00000707291.1 [O94769-1] Q3KR19 O94769 ENST00000344604.10 [O94769-1] ENST00000375540.5 Q5T9F3 |